Pacira BioSciences, Inc. (PCRX) earnings
PCRX earnings moved a median of +0.57% by the close. Quarterly and annual PCRX reports and results, each read against the price at its own news timestamp. Back to the PCRX overview →
30 measured PCRX earnings events.
Where these PCRX earnings landedvs 30 measured PCRX earnings reactions
| Middle 50% of PCRX earnings reactions | -1.35% to +2.32% |
|---|---|
| Median reaction (to close) | +0.57% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 PCRX earnings events with a measured close landed between -1.35% and +2.32%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Pacira BioSciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.88% | -4.57% | |
| Pacira BioSciences Reports Second Quarter 2026 Financial Results | Press release | -2.88% | -4.57% | |
| Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026 | Press release | -0.74% | -0.58% | |
| Form 10-Q Pacira BioSciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.34% | -9.14% | |
| Pacira BioSciences Reports First Quarter 2026 Financial Results | Press release | -1.34% | -9.14% | |
| Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026 | Press release | -0.17% | +0.89% | |
| Form 10-K Pacira BioSciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.38% | +3.64% | |
| Form 10-Q Pacira BioSciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +10.97% | +8.51% | |
| Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance | Press release | +10.97% | +8.51% | |
| Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 | Press release | -0.33% | +1.04% | |
| Form 10-Q Pacira BioSciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.21% | +0.67% | |
| Pacira BioSciences Reports Second Quarter 2025 Financial Results | Press release | +1.21% | +0.67% | |
| Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025 | Press release | -0.27% | -1.49% | |
| Form 10-Q Pacira BioSciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +6.15% | +9.22% | |
| Pacira BioSciences Reports First Quarter 2025 Financial Results | Press release | +6.15% | +9.22% | |
| Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025 | Press release | -0.42% | -0.18% | |
| Form 10-K Pacira BioSciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.04% | -7.50% | |
| Form 10-Q Pacira BioSciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.33% | +0.68% | |
| Pacira BioSciences Reports Third Quarter 2024 Financial Results | Press release | -2.33% | +0.68% | |
| Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024 | Press release | -0.12% | -0.65% | |
| Form 10-Q Pacira BioSciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.48% | -6.94% | |
| Pacira BioSciences Reports Second Quarter 2024 Financial Results | Press release | -2.48% | -6.94% | |
| Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024 | Press release | +0.20% | -0.65% | |
| Form 10-Q Pacira BioSciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.83% | +2.60% | |
| Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program | Press release | +1.83% | +2.60% | |
| Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 | Press release | -1.62% | +1.51% | |
| Form 10-K Pacira BioSciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.03% | -0.93% | |
| Form 10-Q Pacira BioSciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.29% | +0.47% | |
| Pacira BioSciences Reports Third Quarter 2023 Financial Results | Press release | -0.39% | +3.15% | |
| Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023 | Press release | +0.00% | -0.51% |
Keep exploring
More PCRX: analyst actions → · SEC filings → · PCRX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Epizyme, Inc. (EPZM) | 1,145 | +0.04% | 51% |
| Neogen Corporation (NEOG) | 1,143 | 0.00% | 48% |
| Anthem, Inc. (ANTM) | 1,140 | -0.01% | 49% |
| EXPRESS SCRIPTS (ESRX) | 1,137 | +0.02% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.